# Mesenchymal Stem Cells in NPM1 Mutated Low Risk Acute Myeloid Leukemia: a Study of the Tumor Microenvironment and Its Contribution to the Outcome

> **NCT07379528** · — · COMPLETED · sponsor: **Fondazione IRCCS Policlinico San Matteo di Pavia** · enrollment: 70 (actual)

## Conditions studied

- Acute Myeloid Leukaemia (AML)

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07379528
- **Lead sponsor:** Fondazione IRCCS Policlinico San Matteo di Pavia
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2023-03-15
- **Primary completion:** 2025-02-01
- **Final completion:** 2025-03-15
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2026-01-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07379528

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07379528, "Mesenchymal Stem Cells in NPM1 Mutated Low Risk Acute Myeloid Leukemia: a Study of the Tumor Microenvironment and Its Contribution to the Outcome". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07379528. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*